Ignite Creation Date:
2024-05-06 @ 7:51 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06162195
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-12-08
First Post:
2023-11-29
Brief Title:
The ACTIVE Trial A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
Sponsor:
Embody Orthopaedic Limited
Organization:
Embody Orthopaedic Limited
Study Overview
Official Title:
The ACTIVE Trial A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACTIVE
Brief Summary:
The goal of this randomised controlled trial is to compare the success of two types of hip replacement in patients with hip arthritis The main question it aims to answer is whether a new type of hip replacement called a hip resurfacing can be as successful as an existing hip replacement called a total hip replacement Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare their function complication rate and physical activity
Detailed Description:
The H1 Implant is a cementless ceramic hip resurfacing arthroplasty HRA device The intended purpose of the H1 Implant is to provide an artificial substitute for a disease-damaged hip joint to replace the articulating surfaces of the hip while preserving the underlying femoral head and natural femoral neck This is standard for a resurfacing hip prosthesis This study will randomise patients to receive either The H1 Implant or a primary cementless ceramic-on-poly or ceramic-on-ceramic total hip replacement THR Composite clinical success CCS scores physical activity levels and patient reported outcome measures PROMs will be compared for the two groups The primary objective of the study is to determine whether the H1 Implant is non-inferior to cementless THR in terms of CCS The key secondary objective is to determine whether the H1 Implant is superior compared to cementless THR in terms of physical activity and PROMs Other secondary objectives are to compare the H1 Implant and THR with respect to safety through collection of all device-related operative site-related and systemic adverse events and noise generation through patient survey
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None